Lal, N., White, B. S., Goussous, G., Pickles, O., Mason, M. J., Beggs, A. D., . . . Middleton, G. W. (2017). KRAS mutation and Consensus Molecular Subtypes 2 and 3 are independently associated with reduced immune infiltration and reactivity in colorectal cancer. Clin Cancer Res.
Styl ChicagoLal, Neeraj, et al. "KRAS Mutation and Consensus Molecular Subtypes 2 and 3 Are Independently Associated With Reduced Immune Infiltration and Reactivity in Colorectal Cancer." Clin Cancer Res 2017.
Citace podle MLALal, Neeraj, et al. "KRAS Mutation and Consensus Molecular Subtypes 2 and 3 Are Independently Associated With Reduced Immune Infiltration and Reactivity in Colorectal Cancer." Clin Cancer Res 2017.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..